229 related articles for article (PubMed ID: 32339493)
1. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
3. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
4. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
Pieters FA; Woonink F; Zuidema J
Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
[TBL] [Abstract][Full Text] [Related]
5. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
6. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Lepr Rev; 1986; 57 Suppl 3():67-76. PubMed ID: 3573964
[No Abstract] [Full Text] [Related]
7. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Chakraborty A; Ghosh R; Biswas A
FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
[TBL] [Abstract][Full Text] [Related]
8. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
[TBL] [Abstract][Full Text] [Related]
9. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
10. The chemotherapy of leprosy. Part 1.
Ellard GA
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
[No Abstract] [Full Text] [Related]
11. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Soares DJ; Neupane K; Britton WJ
Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
[TBL] [Abstract][Full Text] [Related]
12. Determination of three main antileprosy drugs and their main metabolites in serum by high-performance liquid chromatography.
Gidoh M; Tsutsumi S; Takitani S
J Chromatogr; 1981 May; 223(2):379-92. PubMed ID: 7251793
[TBL] [Abstract][Full Text] [Related]
13. The immunopharmacology of antileprosy agents.
Anderson R
Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
[No Abstract] [Full Text] [Related]
14. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
Degang Y; Akama T; Hara T; Tanigawa K; Ishido Y; Gidoh M; Makino M; Ishii N; Suzuki K
PLoS Negl Trop Dis; 2012; 6(12):e1936. PubMed ID: 23236531
[TBL] [Abstract][Full Text] [Related]
15. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
Balakrishnan ; Seshadri PS
Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
Ahuja M; Singh I; Lavania M; Pathak VK; Darlong J; Turankar RP; Hembrom S; Singh SV; Sengupta U
J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
[TBL] [Abstract][Full Text] [Related]
18. Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
Schalcher TR; Borges RS; Coleman MD; Batista Júnior J; Salgado CG; Vieira JL; Romão PR; Oliveira FR; Monteiro MC
PLoS One; 2014; 9(1):e85712. PubMed ID: 24465659
[TBL] [Abstract][Full Text] [Related]
19. Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine.
Sahu A; Saha K; Banerjee NR; Sehgal VN; Jagga CR
Int J Immunopharmacol; 1991; 13(4):419-28. PubMed ID: 1646774
[TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical studies on rifampicin in treatment of leprosy.
Rees RJ; Pearson JM; Waters MF
Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
